Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm, Qiagen to Develop Gene Expression Panels

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm today said that it has partnered with Qiagen's SABiosciences to create more than 100 pathway-focused gene expression panels to run on Fluidigm's BioMark System for Genetic Analysis.

The kits, called RT2 Profiler PCR Arrays, will be validated for real-time PCR analysis on the BioMark system. Each reagent kit will include pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for pre-amplification and pathway-focused analysis, said Fluidigm. The PCR Arrays will contain enough reagents to run five of Fluidigm's 96.96 Dynamic Array chips.

"SABiosciences solutions focusing on the analysis of pathways with real time assay panel kits are an excellent fit to our products," Mike Lee, Fluidigm's senior director of marketing, said in a statement. "The kits include 96 cataloged gene expression assays, targeting genes in signal transduction, biological process, and disease-related pathways."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.